GG
ACAD icon

Gofen & Glossberg’s Acadia Pharmaceuticals ACAD Stock Holding History

Gofen & Glossberg’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,155
Closed -$164K – 445
2018
Q4 		$164K Hold
10,155
– – 0.01% 406
2018
Q3 		$211K Buy
+10,155
New +$211K 0.01% 426